The Role of Different Molecular Markers in Papillary Thyroid Cancer Patients with Acromegaly

Keskin, Fatma; Ozkaya, Hande; Ferahman, Sina; Haliloglu, Ozlem; Karatas, Adem; Aksoy, Oğuz; Kadioglu, Pınar

doi:10.1055/a-0629-9223

The Role of Different Molecular Markers in Papillary Thyroid Cancer Patients with Acromegaly

Keskin F. E., Ozkaya H. M., Ferahman S., Haliloglu O., Karatas A., Aksoy F., ...Daha Fazla

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.127, sa.7, ss.437-444, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 127 Sayı: 7
Basım Tarihi: 2019
Doi Numarası: 10.1055/a-0629-9223
Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.437-444
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose Prevalence of papillary thyroid cancer (PTC) is increased in patients with acromegaly. We aimed to determine the protein expression of BRAF, RAS, RET, insulin like growth factor 1(IGF1), Galectine 3, CD56 in patients with PTC related acromegaly and to compare the extensity of these expressions with normal PTC patients and benign thyroid nodules.